Cargando…
Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
An octahydroisochromene scaffold has been introduced into a known SARS 3CL protease inhibitor as a novel hydrophobic core to interact with the S2 pocket of the protease. An alkyl or aryl substituent was also introduced at the 1-position of the octahydroisochromene scaffold and expected to introduce...
Autores principales: | Yoshizawa, Shin-ichiro, Hattori, Yasunao, Kobayashi, Kazuya, Akaji, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127348/ https://www.ncbi.nlm.nih.gov/pubmed/31926775 http://dx.doi.org/10.1016/j.bmc.2019.115273 |
Ejemplares similares
-
Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor
por: Ohnishi, Kouji, et al.
Publicado: (2019) -
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
por: Shimamoto, Yasuhiro, et al.
Publicado: (2015) -
The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
por: Awahara, Chiyuki, et al.
Publicado: (2022) -
Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor
por: Konno, Hiroyuki, et al.
Publicado: (2017) -
Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
por: Konno, Hiroyuki, et al.
Publicado: (2016)